1-Propionyl-LSD, a relatively new analog of the copyright drug LSD, is increasingly appearing in the research community and online marketplaces. Originally synthesized as a prospective research tool, it’s eliciting interest due to its supposedly different efficacy compared to LSD, though scant human studies are currently accessible . The absence